Cleveland Biolabs Inc (NASDAQ:CBLI)

2.71
Delayed Data
As of May 25
 -0.09 / -3.21%
Today’s Change
2.24
Today|||52-Week Range
4.36
-32.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues206.2K296.9K870.4K227.6K
 
 
 
 
 
Depreciation And Amortization5.9K5.2K4.3K4.9K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses1.8M1.5M2.1M2.1M
 
 
 
 
 
Research And Development1.2M919.1K1.5M1.3M
 
 
 
 
 
Total Operating Expenses1.8M1.5M2.1M2.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.6M-1.2M-1.2M-1.8M
 
 
 
 
 
Extraordinary Credit0.000.000.00508.5K
 
 
Extraordinary Charge-4.1M-166.3K-14.2K0.00
 
 
 
 
Other Expenses-4.1K-450.00-750.00-380.00
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.6M-1.3M-1.2M-1.3M
 
 
 
 
 
Minority Interest-35.4K-35.5K-29.0K-33.8K
 
 
 
 
 
Net Income-5.6M-1.3M-1.2M-1.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.2M11.3M11.3M11.3M
 
 
 
 
 
Shares To Calculate EPS Diluted11.2M11.3M11.3M11.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.50-$0.11-$0.10-$0.11
 
 
 
 
 
EPS Diluted-$0.50-$0.11-$0.10-$0.11